Skip to main content
TipRanks
Go Ultimate75% OFF

Kevin Young Insider Profile

4 Followers

Kevin Young, Director at IRulya Therapeutics, holds 30.00K shares in IRulya Therapeutics (Ticker: IRLA), holds 25.61K shares in Gilead Sciences (Ticker: GILD). Most recently, Kevin Young Bought ― shares of IRulya Therapeutics on Mar 12, 2020 for an estimated value of $510.00K.

Kevin Young's Trading History

IRLA
IRulya Therapeutics
Mar 12, 2020DirectorInformative Buy510.00K$1.12M
GILD
Gilead Sciences
Feb 23, 2018COOUninformative Buy21.20K$4.29M

You May Also Like

Kevin Young insider profile FAQ

What is the percentage of profitable transactions made by Kevin Young?
The percentage of profitable transactions made by Kevin Young is 50%.
What is the average return per transaction made by Kevin Young?
The average return per transaction made by Kevin Young is 1.80%.
What stocks does Kevin Young hold?
Kevin Young holds: IRLA, GILD stocks.
What was Kevin Young’s latest transaction?
Kevin Young’s latest transaction was an Informative Buy of $510.00K.
What was Kevin Young's most profitable transaction?
Kevin Young’s most profitable transaction was an Informative Buy of IRLA stock on March 12, 2020. The return on the trade was 36.70%.
What is Kevin Young's role in IRulya Therapeutics?
Kevin Young's role in IRulya Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.